diuretics + ACE inhibitor + beta-blocker + aldosterone antagonist

**This regimen is a combination therapy comprising four different classes of antihypertensive medications:** diuretics, angiotensin-converting enzyme (ACE) inhibitors, beta-blockers, and aldosterone antagonists. These agents have distinct yet complementary mechanisms and are used together primarily in the management of heart failure, especially with reduced ejection fraction, and sometimes in resistant hypertension or patients with significant comorbidities like diabetes or chronic kidney disease. - **Diuretics** promote excretion of sodium and water by the kidneys, reducing blood volume and relieving symptoms such as edema and breathlessness. - **ACE inhibitors** prevent the conversion of angiotensin I to angiotensin II, lowering vascular resistance and blood pressure, and providing cardioprotective effects. - **Beta-blockers** inhibit beta-adrenergic effects of the sympathetic nervous system, reducing heart rate, myocardial contractility, and helping prevent progression of heart failure. - **Aldosterone antagonists** inhibit the effects of aldosterone, further promoting sodium excretion and potassium retention, and are particularly effective in reducing hospitalizations and mortality in heart failure patients. The use of this multidrug regimen targets multiple pathophysiological pathways in cardiovascular disease, offering additive or synergistic therapeutic effects[1][2][3][4][5][7].